CJC-1295 No DAC + Ipamorelin: Benefits, Dosage, Side Effects and Risks
What CJC-1295 without DAC and ipamorelin are, how the pair is meant to raise growth hormone, the research, side effects, doses and FDA status.
Growth Hormone Peptides
CJC-1295, ipamorelin, sermorelin, tesamorelin and other growth hormone secretagogues: how they work and what the research shows.
Peptide profiles
- Not FDA-approved
AOD-9604
AOD9604 · Anti-Obesity Drug 9604 · Tyr-hGH (177-191)
Modified growth hormone fragment (16 amino acids)
A modified fragment of growth hormone developed in Australia as a fat-loss drug. It worked in obese mice, but its largest human trial found no weight loss.
Read profile → - Not FDA-approved
CJC-1295 with DAC
CJC-1295 DAC · DAC:GRF
Growth hormone-releasing hormone (GHRH) analog
A long-acting growth hormone-releasing hormone analog. It raised growth hormone and IGF-1 for days in healthy adults, but development stopped in 2006.
Read profile → - Not FDA-approved
MK-677 (Ibutamoren)
Ibutamoren · Ibutamoren mesylate · MK-0677 · L-163,191 · LUM-201
Oral ghrelin-receptor agonist (non-peptide growth hormone secretagogue)
An oral pill that mimics ghrelin to raise growth hormone. It added lean mass in older adults but raised blood sugar, and a trial was stopped over heart failure.
Read profile → - Discontinued
Sermorelin
Geref (discontinued) · GHRH (1-29) · Sermorelin acetate
Growth hormone-releasing hormone (GHRH) analog
A short GHRH analog that was FDA-approved for growth hormone deficiency in children, discontinued in 2008, and is now widely used by anti-aging clinics.
Read profile → - FDA-approved
Tesamorelin
Egrifta · Egrifta SV · Egrifta WR · TH9507 · Tesamorelin acetate
Growth hormone-releasing hormone (GHRH) analog
An FDA-approved growth hormone-releasing hormone analog that reduces deep belly fat in adults with HIV-associated lipodystrophy.
Read profile →
Guides and research
The Weekly Peptide Brief
FDA updates and new research, explained in 5 minutes. Every week, free.
Free. Unsubscribe anytime. We never sell your email.